
|Articles|October 1, 2003
Molecular forms of PSA: What does the future hold?
Among urologic tumor markers, the discovery and application of prostate-specific antigen has established PSA as a vital tool for the early diagnosis, staging, and monitoring of men with prostate cancer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











